Frequent low-dose misoprostol for termination of second-trimester pregnancy
- PMID: 15352690
- DOI: 10.1080/13625180410001696232
Frequent low-dose misoprostol for termination of second-trimester pregnancy
Abstract
Objectives: To determine the efficacy of an application regimen of low-dose frequent misoprostol for second-trimester pregnancy termination.
Methods: A total of 250 women between 12 and 20 weeks of gestation who were scheduled for second-trimester pregnancy termination received 200 microg vaginal misoprostol followed by 100 microg oral misoprostol every 2 h until expulsion of the fetus. Mechanical cervical dilatation with a 16-French Foley balloon catheter was performed if no cervical dilatation was observed after 24 h. The main outcome measures were the delivery rate within 24 h and the factors influencing the interval between the onset of induction and abortion. Secondary outcome measures were the side-effects of the regimen and the total misoprostol dose required.
Results: With application of this protocol, 245 women (98%) delivered within 24 h of induction. The mean (+/-standard deviation) misoprostol dose used was 728+/-297 microg (200-2100 microg). Cox regression analysis revealed that vaginal spotting or nulliparity do not effect the induction-abortion time. On the other hand, using this regimen induction to abortion time tends to be longer in the presence of live fetuses (odds ratio (OR) = 0.45; confidence interval (CI) =0.2-0.8; p=0.008) and pregnancies with gestational age > 16 weeks (OR= 0.59; CI = 0.4-0.8; p= 0.003) when compared with cases of in utero death and pregnancies with a gestational age of 12-13 weeks, respectively. Twenty-seven women (10.8%) experienced one or more side-effects attributable to misoprostol.
Conclusion: The 100-microg oral misoprostol every 2 h following 200 microg vaginal misoprostol is a highly effective protocol for inducing abortion at 12-20 weeks of pregnancy. Cases with live fetuses or pregnancies with older gestational age (> 16 weeks) deliver in a longer time period.
Similar articles
-
Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.Fetal Diagn Ther. 2005 Nov-Dec;20(6):544-8. doi: 10.1159/000088048. Fetal Diagn Ther. 2005. PMID: 16260893 Clinical Trial.
-
Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.Hum Reprod. 2000 Oct;15(10):2205-8. doi: 10.1093/humrep/15.10.2205. Hum Reprod. 2000. PMID: 11006200 Clinical Trial.
-
Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.J Matern Fetal Neonatal Med. 2019 Nov;32(22):3703-3707. doi: 10.1080/14767058.2018.1470236. Epub 2018 May 9. J Matern Fetal Neonatal Med. 2019. PMID: 29742942 Clinical Trial.
-
Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S178-81. doi: 10.1016/j.ijgo.2007.09.007. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961566 Review.
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical